A detailed history of Ruffer LLP transactions in Pfizer Inc stock. As of the latest transaction made, Ruffer LLP holds 5,728,695 shares of PFE stock, worth $157 Million. This represents 7.01% of its overall portfolio holdings.

Number of Shares
5,728,695
Previous 5,907,658 3.03%
Holding current value
$157 Million
Previous $164 Million 2.23%
% of portfolio
7.01%
Previous 6.43%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$25.26 - $29.6 $4.52 Million - $5.3 Million
-178,963 Reduced 3.03%
5,728,695 $160 Million
Q1 2024

May 08, 2024

BUY
$25.89 - $29.73 $2.89 Million - $3.32 Million
111,646 Added 1.93%
5,907,658 $164 Million
Q4 2023

Feb 12, 2024

BUY
$26.13 - $33.94 $108 Million - $140 Million
4,133,786 Added 248.69%
5,796,012 $167 Million
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $15.7 Million - $18.3 Million
489,177 Added 41.7%
1,662,226 $55.1 Million
Q2 2023

Aug 10, 2023

BUY
$36.12 - $41.79 $3.66 Million - $4.24 Million
101,370 Added 9.46%
1,173,049 $43 Million
Q1 2023

May 11, 2023

BUY
$39.39 - $51.28 $20 Million - $26.1 Million
508,764 Added 90.38%
1,071,679 $43.7 Million
Q4 2022

Feb 10, 2023

BUY
$41.75 - $54.5 $339,845 - $443,630
8,140 Added 1.47%
562,915 $28.9 Million
Q3 2022

Nov 10, 2022

BUY
$43.76 - $53.42 $441,538 - $539,007
10,090 Added 1.85%
554,775 $23.9 Million
Q2 2022

Aug 05, 2022

SELL
$46.53 - $55.17 $1.58 Million - $1.87 Million
-33,949 Reduced 5.87%
544,685 $28.6 Million
Q1 2022

May 12, 2022

BUY
$45.75 - $56.69 $882,060 - $1.09 Million
19,280 Added 3.45%
578,634 $30 Million
Q4 2021

Feb 04, 2022

BUY
$41.32 - $61.25 $5.14 Million - $7.62 Million
124,464 Added 28.62%
559,354 $31.8 Million
Q3 2021

Nov 10, 2021

BUY
$39.25 - $50.42 $8.91 Million - $11.4 Million
227,047 Added 109.24%
434,890 $18.6 Million
Q2 2021

Aug 06, 2021

BUY
$35.91 - $40.68 $7.46 Million - $8.46 Million
207,843 New
207,843 $8.14 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Ruffer LLP Portfolio

Follow Ruffer LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ruffer LLP, based on Form 13F filings with the SEC.

News

Stay updated on Ruffer LLP with notifications on news.